Gene · 2826
Papers2,000
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,000
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Vitamin A deficiency and vitamin A supplementation affect innate and T cell immune responses to rotavirus A infection in a conventional sow model. | Front Immunol | 2023 | 37180172 | PubTator, text mining | PubMed |
| Human induced pluripotent stem cells (hiPSC), enveloped in elastin-like recombinamers for cell therapy of type 1 diabetes mellitus (T1D): preliminary data. | Front Bioeng Biotechnol | 2023 | 37180045 | PubTator, text mining | PubMed |
| Intestinal Behcet's Disease: A Review of the Immune Mechanism and Present and Potential Biological Agents. | Int J Mol Sci | 2023 | 37175882 | PubTator, text mining | PubMed |
| Differential Response of Mycosis Fungoides Cells to Vorinostat. | Int J Mol Sci | 2023 | 37175780 | PubTator, text mining | PubMed |
| Multi-Omics Research Strategies for Psoriasis and Atopic Dermatitis. | Int J Mol Sci | 2023 | 37175722 | PubTator, text mining | PubMed |
| Chemokines as possible therapeutic targets in metastatic melanoma. | Cancer Med | 2023 | 37170733 | PubTator, text mining | PubMed |
| Pan-cancer analysis of SYNGR2 with a focus on clinical implications and immune landscape in liver hepatocellular carcinoma. | BMC Bioinformatics | 2023 | 37170221 | PubTator, text mining | PubMed |
| Exome sequence analysis of rare frequency variants in Late-Onset Alzheimer Disease. | Metab Brain Dis | 2023 | 37162726 | PubTator, text mining | PubMed |
| Identification of potential resistance mechanisms and therapeutic targets for the relapse of BCMA CAR-T therapy in relapsed/refractory multiple myeloma through single-cell sequencing. | Exp Hematol Oncol | 2023 | 37158921 | PubTator, text mining | PubMed |
| New pairings and deorphanization among the atypical chemokine receptor family - physiological and clinical relevance. | Front Immunol | 2023 | 37153591 | PubTator, text mining | PubMed |
| Immune Cell Profiling of Atopic Dermatitis Patients Before and After Treatment with Halometasone Cream Wet-Wrap Therapy by Single-Cell Sequencing. | Indian J Dermatol | 2023 | 37151231 | PubTator, text mining | PubMed |
| Unique molecular signatures sustained in circulating monocytes and regulatory T cells in convalescent COVID-19 patients. | Clin Immunol | 2023 | 37150240 | PubTator, text mining | PubMed |
| Weighted gene co-expression network analysis identifies the prognosis-related models of left- and right-sided colon cancer. | Medicine (Baltimore) | 2023 | 37144998 | PubTator, text mining | PubMed |
| Breast Cancer Stem Cell-Derived Tumors Escape from γδ T-cell Immunosurveillance In Vivo by Modulating γδ T-cell Ligands. | Cancer Immunol Res | 2023 | 37139603 | PubTator, text mining | PubMed |
| Cutaneous lesions in psoriatic arthritis are enriched in chemokine transcriptomic pathways. | Arthritis Res Ther | 2023 | 37131254 | PubTator, text mining | PubMed |
| Mycosis fungoides and Sézary syndrome: clinical presentation, diagnosis, staging, and therapeutic management. | Front Oncol | 2023 | 37124514 | PubTator, text mining | PubMed |
| Intelligent optimization for modelling superhydrophobic ceramic membrane oil flux and oil-water separation efficiency: Evidence from wastewater treatment and experimental laboratory. | Chemosphere | 2023 | 37116721 | PubTator, text mining | PubMed |
| Early Oral Administration of Ginseng Stem-Leaf Saponins Enhances the Peyer's Patch-Dependent Maternal IgA Antibody Response to a PEDV Inactivated Vaccine in Mice, with Gut Microbiota Involvement. | Vaccines (Basel) | 2023 | 37112742 | PubTator, text mining | PubMed |
| Severe COVID-19: Drugs and Clinical Trials. | J Clin Med | 2023 | 37109231 | PubTator, text mining | PubMed |
| Regulatory Mechanisms and Reversal of CD8+T Cell Exhaustion: A Literature Review. | Biology (Basel) | 2023 | 37106742 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2826/papers?page=11